|
|||||
|
|
Proof‐of‐Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence |
|
| Authors: | Anke Post Trevor S Smart Kimberley Jackson Joanne Mann Richard Mohs Linda Rorick‐Kehn Michael Statnick Raymond Anton Stephanie S O'Malley Conrad J Wong |
| Institution: | 1. Lilly UK, Windlesham, Surrey, UK;2. JStat Services, Ltd, Wokingham, Berkshire, UK;3. Eli Lilly and Company, Indianapolis, Indiana;4. Medical University of South Carolina, Charleston, South Carolina;5. Yale School of Medicine, New Haven, Connecticut |
| Abstract: | |
| Keywords: | Alcohol Dependence LY2940094 Nociceptin/Orphanin FQ Peptide Receptor |